Read some of the latest prostate cancer NEWS You Can Use from Us TOO

Prostate Cancer News You Can Use from Us TOO provides some of the latest news articles on prostate cancer and is distributed via email each month at no charge.

Subscribe to get Prostate Cancer News You Can Use (and other news and information) for free via email from Us TOO at www.ustoo.org/subscribe.

Made possible by a charitable contribution from




Opt-In
to receive prostate cancer news articles from Us TOO


Treatment hope as scientists find gene that powers spread of prostate cancer

By Mark Waghorn A GENE that fuels the spread of prostate cancer has been discovered by scientists. The protein makes tumours more aggressive, helping them migrate to other organs

In Recurrent Prostate Cancer, Prostate-Specific Membrane Antigen PET/CT Changes Management in Two-Thirds of Cases

RESTON, Virginia, July 14 -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:New research confirms the high impact of PSMA PET/CT in the

LARGEST-EVER STUDY OF PROSTATE CANCER GENOMICS IN BLACK MEN IDS POTENTIAL TARGETS FOR PRECISION THERAPIES

The following information was released by UCSF Medical Center: Black Patients Should Also Benefit from Recently Approved PARP Inhibitor Therapies "If Applied Equitably," Study

Researchers Submit Patent Application, “Systems And Methods For Treating Cancer Using Brachytherapy”, for Approval (USPTO 20200187769)

2020 JUL 06 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily -- From Washington, D.C., NewsRx journalists report that a patent application by the

University of Illinois Chicago Reports Findings in Prostatectomy (Single port robotic radical prostatectomy with the da Vinci SP platform: a step by step approach)

2020 JUL 01 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Medical Devices Daily -- Research findings on Surgery - Prostatectomy are discussed in a new report

Johns Hopkins - Loss of Lipid-Regulating Gene Fuels Prostate Cancer Spread

Johns Hopkins Kimmel Cancer Center researchers from the Department of Radiation Oncology and Molecular Radiation Sciences identified a lipid-regulating protein that conveys what

Department of Radiation Oncology Reports Findings in Prostate Cancer (Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry)

2020 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news originating

New Prostate Cancer Study Findings Have Been Reported by Researchers at Ohio State University College of Medicine (Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range)

2020 JUN 08 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news

Recent Studies from Northwestern University Add New Data to Prostate Cancer (Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review)

2020 JUN 04 (NewsRx) -- By a News Reporter-Staff News Editor at Disease Prevention Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news

Data from University of Michigan Provide New Insights into Prostatectomy (Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy)

2020 JUN 03 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Medical Devices Daily -- Investigators publish new report on Surgery - Prostatectomy. According to news

“Erectile Dysfunction Treatment System And Method” in Patent Application Approval Process (USPTO 20200146870)

2020 JUN 01 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily -- A patent application by the inventor Castaneda, Sergio (Las Vegas, NV), filed on

Findings on Prostate Cancer Detailed by Researchers at University of Illinois Urbana-Champaign (Dietary Tomato or Lycopene Do Not Reduce Castration-Resistant Prostate Cancer Progression in a Murine Model)

2020 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news originating from

Studies from Duke University School of Medicine Reveal New Findings on Prostate Cancer (Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer)

2020 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Daily -- Fresh data on Oncology - Prostate Cancer are presented in a new report. According to

VA Launches Clinical Trial for Veterans With COVID-19 Based on Prostate Cancer Drug

WASHINGTON, May 16 -- The U.S. Department of Veterans Affairs issued the following news release:The U.S. Department of Veterans Affairs (VA) began a new clinical trial to test a

Androgen-deprivation treatments for prostate cancer could protect men from COVID-19

2020 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at CDC & FDA Daily -- A study of 4532 men in the Veneto region of Italy has found that those who were being treated for

Myriad Receives FDA Approval of BRACAnalysis CDx® as a Companion Diagnostic for Lynparza® in HRR-mutated Metastatic Castration-Resistant Prostate Cancer

SALT LAKE CITY, May 20, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food

LYNPARZA® (Olaparib) Approved in the US for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP inhibitor to improve overall survival vs enzalutamide or abiraterone in the biomarker-based subset of prostate cancer patients with BRCA1/2 or ATM mutations Approximately


Receive emails from Us TOO including the HotSheet e-newsletter and the latest Prostate Cancer News You Can Use each month.

Subscribe to the news feed and emails from Us TOO.

Click here to Subscribe